Abu Dhabi’s International Holdings Company invested £39 million ($51m) in Oxford Nanopore Technologies, a UK based firm that specialises in DNA sequencing technology.
The latest investment is part of Oxford Nanopore’s £84.4m equity raising exercise and will help the company boost its Covid-19 testing capability, IHC said in a statement on Tuesday.
“IHC has a strong track record in the healthcare device sector in the Middle East and we are very pleased to be expanding our interests globally,” Syed Basar Shueb, chief executive and managing director of IHC, said. “Oxford Nanopore has developed distinctive and proven technology and has been highly effective in taking products from innovation to market within tight timeframes.”
Credits and Original Resources from :
